Clinical Research Division, Fred Hutch
Dr. Rachel Yung is a medical oncologist who studies new ways to treat breast cancer. She leads clinical trials that aim to identify unique signatures on cancer cells that could help improve outcomes and reduce side effects from treatments such as chemotherapy and hormone therapy. Dr. Yung also studies how lifestyle can influence the quality of care, patient-reported outcomes, prevention and survivorship of cancer.
Assistant Professor, Medical Oncology Division
University of Washington
B.S., University of Nebraska
M.D., Harvard Medical School
Clinical Internship, Internal Medicine, Beth Israel Deaconess Medical Center
Residency, Internal Medicine, Beth Israel Deaconess Medical Center
Clinical Fellowship, Medical Oncology, Dana‐Farber Cancer Institute, Brigham and Women’s Hospital, Massachusetts General Hospital
Research Fellowship, Medical Oncology, Dana‐Farber Cancer Institute
Dr. Yung realizes the impact that a cancer diagnosis makes on a person's life. She feels that it is an honor to provide care to patients and their families during such an important time in their lives. "My research focuses on the effect of lifestyle on cancer, quality of care, patient reported outcomes, prevention and survivorship," she says.
In addition to the connection she feels to her patients, Dr. Yung is helping to implement new treatment options through Seattle Cancer Care Alliance's clinical trials program. She believes that offering research opportunities to patients is an important part of the care provided at SCCA. "Already in my career, I have seen amazing developments in breast cancer therapy in regards to more effective and less toxic therapies," she says. "I remain dedicated to both improving cancer outcomes and reducing side effects."